Logos Global Management LP

Position in COGT — Cogent Biosciences, Inc.

CIK 1792126 San Francisco, CA

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$34,830,000

+$27,650,000 QoQ

Shares Held

900,000

+80.0% QoQ

Ownership

0.519%

of shares outstanding

% of Portfolio

1.50%

of 13F equity value

Holder Rank

#48

of 321 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. COGT ranks #22 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc.	12,150,000	$222,588,000
2	ABVX	Abivax S.A.	1,024,000	$136,458,240
3	RVMD	Revolution Medicines, Inc.	700,000	$131,096,000
4	IDYA	IDEAYA Biosciences, Inc.	3,000,000	$111,810,000
5	BNTX	BioNTech SE	1,015,000	$94,445,750
6	VERA	Vera Therapeutics, Inc.	2,200,000	$94,402,000
7	TNGX	Tango Therapeutics, Inc.	2,850,000	$89,091,000
8	PRAX	Praxis Precision Medicines, Inc.	260,000	$87,045,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,830,000	900,000	+80.0%	Shares	Sole	2026-08-14
2025-09-30	$7,180,000	500,000	-75.0%	Shares	Sole	2025-11-14
2024-09-30	$21,600,000	2,000,000	+150.0%	Shares	Sole	2024-11-14
2023-06-30	$9,472,000	800,000	-20.0%	Shares	Sole	2023-08-14
2023-03-31	$10,790,000	1,000,000	-9.1%	Shares	Sole	2023-05-15
2022-12-31	$12,716,000	1,100,000	+633.3%	Shares	Sole	2023-02-14
2022-03-31	$1,123,500	150,000	0.0%	Shares	Sole	2022-05-16
2021-12-31	$1,287,000	150,000	-83.8%	Shares	Sole	2022-02-14
2021-09-30	$7,779,250	925,000	-34.9%	Shares	Sole	2021-11-15
2021-03-31	$12,471,990	1,420,500	-26.0%	Shares	Sole	2021-05-17
2020-12-31	$21,567,215	1,920,500	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.